Cargando…
GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19
COVID-19 results in increased expression of inflammatory cytokines, but inflammation-targeting clinical trials have yielded poor to mixed results. Our studies of other disorders with an inflammatory component, including Alzheimer’s disease, chemobrain, Down syndrome, normal aging, and West Nile Viru...
Autores principales: | Kendall, L.V., Boyd, T.D., Sillau, S.H., Bosco-Lauth, A., Markham, N., Fong, D., Clarke, P., Tyler, K.L., Potter, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811947/ https://www.ncbi.nlm.nih.gov/pubmed/35118463 http://dx.doi.org/10.21203/rs.3.rs-1213395/v1 |
Ejemplares similares
-
Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease
por: Potter, Huntington, et al.
Publicado: (2021) -
Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19
por: Potter, Huntington, et al.
Publicado: (2020) -
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023) -
Development of Dendritic Cells from GM-CSF(-/-)
Mice in vitro : GM-CSF Enhances Production
and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)